Please login to the form below
Forixiga
This page shows the latest Forixiga news and features for those working in and with pharma, biotech and healthcare.
AZ gets US approval for diabetes combo Qtern
Qtern is a fixed dose combination product based on the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) and SGLT2 inhibitor Farxiga/Forixiga (dapagliflozin).
Latest news
-
EU clears AZ's FDA-rejected diabetes combination
Qtern combines the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) with SGLT2 inhibitor Farxiga/Forixiga (saxagliptin), and is the second drug of its type on the market after
-
FDA rejects AZ's diabetes combination
The combination of DPP-4 inhibitor saxagliptin - sold by AZ as Onglyza - and SGLT2 inhibitor dapagliflozin (marketed as Farxiga/Forixiga) is considered to be a key component of the company's
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Associate Scientific Director
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Medical Writers Required - Hertfordshire
-
Competitive
-
Sudler London - Account Director
-
Competitive
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Account Manager
-
Negotiable
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Sudler London - Senior Medical Writer
-
Competitive
-
Healthcare PR Senior Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary is DOE
-
Systematic Review Lead- London
-
Negotiable
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
Subscribe to our email news alerts
- Lucid limbers up for second annual sports day
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Hanover Health launches award, Firstlight spins off healthcare arm and more
- J&J files ‘breakthrough’ bladder cancer drug in US
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
